Search

everythinglearnresearchcommunity

for

Search:↓

Gene variation affects prostate issues and hair loss.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Neurosteroids help control dopamine responses in the brain.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

The document concludes that the androgen receptor's structure and function are complex, affecting how it regulates genes and is involved in diseases like prostate cancer.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

5-α reductase inhibitors do not significantly affect male reproductive function but may reduce semen volume.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Certain drugs like Dutasteride and Finasteride might help fight SARS-CoV-2 by increasing levels of a steroid called DHEA, which can protect the heart and increase nitric oxide to counteract the virus.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Male pattern baldness is likely caused by multiple genes, not just 5α-reductase genes.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.